The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, ...

While one brand has withdrawn the affected products, a second, Darwin's Natural Pet Products, has not, according to the FDA.

Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...

The U.S. Food and Drug Administration warns customers to not feed their pets certain lots of these pet food brands as they ...

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...

Shares in Bristol-Myers Squibb (BMY) surged Friday, after the Food and Drug Administration approved the drugmaker's novel ...

Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...

Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This ...

Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them ...

Answers Pet Food and Darwin’s Natural Pet Products, were found to have produced pet food that was contaminated with the ...

The U.S. Food and Drug Administration on Thursday alerted patients and healthcare professionals about the withdrawal of ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...